Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 28, 2024 08:00 ET
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced it will be participating in the H.C. Wainwright 26th...
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
August 12, 2024 07:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
August 08, 2024 06:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
July 16, 2024 07:30 ET
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, July 16, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the “Company”) today announced the approval of a...
Conduit Pharmaceuticals to Join Russell 3000® Index
June 13, 2024 08:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Join Russell 3000® Index
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
March 19, 2024 07:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
March 11, 2024 07:00 ET
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory...
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 31, 2024 08:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
November 02, 2023 08:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
October 11, 2023 08:30 ET
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit Pharmaceuticals” or “Conduit”), a multi-asset clinical-stage disease-agnostic life...